Logo image of OREGE.PA

OREGE (OREGE.PA) Stock Fundamental Analysis

EPA:OREGE - Euronext Paris - Matif - FR0010609206 - Common Stock - Currency: EUR

0.352  -0.01 (-2.22%)

Fundamental Rating

1

Taking everything into account, OREGE scores 1 out of 10 in our fundamental rating. OREGE was compared to 44 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of OREGE have multiple concerns. OREGE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OREGE has reported negative net income.
OREGE had a negative operating cash flow in the past year.
OREGE had negative earnings in each of the past 5 years.
OREGE had a negative operating cash flow in each of the past 5 years.
OREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFOREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of OREGE (-119.56%) is worse than 86.36% of its industry peers.
Industry RankSector Rank
ROA -119.56%
ROE N/A
ROIC N/A
ROA(3y)-71.77%
ROA(5y)-78.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OREGE.PA Yearly ROA, ROE, ROICOREGE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

OREGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OREGE.PA Yearly Profit, Operating, Gross MarginsOREGE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

1

2. Health

2.1 Basic Checks

OREGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OREGE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, OREGE has more shares outstanding
Compared to 1 year ago, OREGE has a worse debt to assets ratio.
OREGE.PA Yearly Shares OutstandingOREGE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
OREGE.PA Yearly Total Debt VS Total AssetsOREGE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

OREGE has an Altman-Z score of -22.46. This is a bad value and indicates that OREGE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OREGE (-22.46) is worse than 79.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -22.46
ROIC/WACCN/A
WACC3.09%
OREGE.PA Yearly LT Debt VS Equity VS FCFOREGE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

OREGE has a Current Ratio of 1.88. This is a normal value and indicates that OREGE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.88, OREGE is doing good in the industry, outperforming 79.55% of the companies in the same industry.
OREGE has a Quick Ratio of 1.88. This is a bad value and indicates that OREGE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, OREGE is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 0.81
OREGE.PA Yearly Current Assets VS Current LiabilitesOREGE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

OREGE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.99%.
OREGE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.12%.
Measured over the past years, OREGE shows a very negative growth in Revenue. The Revenue has been decreasing by -11.04% on average per year.
EPS 1Y (TTM)-26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.64%
Revenue 1Y (TTM)-58.12%
Revenue growth 3Y-14.38%
Revenue growth 5Y-11.04%
Sales Q2Q%13.74%

3.2 Future

OREGE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.60% yearly.
OREGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.38% yearly.
EPS Next Y-17.65%
EPS Next 2Y13.76%
EPS Next 3Y10.6%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y41.42%
Revenue Next 3Y49.38%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OREGE.PA Yearly Revenue VS EstimatesOREGE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
OREGE.PA Yearly EPS VS EstimatesOREGE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OREGE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OREGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OREGE.PA Price Earnings VS Forward Price EarningsOREGE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OREGE.PA Per share dataOREGE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.76%
EPS Next 3Y10.6%

More info and screens

0

5. Dividend

5.1 Amount

OREGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OREGE

EPA:OREGE (3/25/2025, 7:00:00 PM)

0.352

-0.01 (-2.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-24 2024-10-24
Earnings (Next)04-28 2025-04-28/amc
Inst Owners2.64%
Inst Owner ChangeN/A
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap17.81M
Analysts40
Price Target0.41 (16.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.86
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.03
BVpS-0.89
TBVpS-0.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-71.77%
ROA(5y)-78.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.04%
Cap/Sales 16.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 0.81
Altman-Z -22.46
F-Score1
WACC3.09%
ROIC/WACCN/A
Cap/Depr(3y)12.03%
Cap/Depr(5y)17.28%
Cap/Sales(3y)12.51%
Cap/Sales(5y)14.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.64%
EPS Next Y-17.65%
EPS Next 2Y13.76%
EPS Next 3Y10.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-58.12%
Revenue growth 3Y-14.38%
Revenue growth 5Y-11.04%
Sales Q2Q%13.74%
Revenue Next Year0%
Revenue Next 2Y41.42%
Revenue Next 3Y49.38%
Revenue Next 5YN/A
EBIT growth 1Y-41.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40%
EBIT Next 3Y6.27%
EBIT Next 5YN/A
FCF growth 1Y-7.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.72%
OCF growth 3YN/A
OCF growth 5YN/A